During the past decade, Dekalb Medical Center conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 55 clinical trials were completed, i.e. on average, 152.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 33 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dekalb Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 44 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "Gynecologic Oncology Group" with 5 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dekalb Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Dekalb Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (6 trials) and "Stage II Breast Cancer" (6 trials). Many other conditions were trialed in "Dekalb Medical Center" in a lesser frequency.

Most popular intervention types in "Dekalb Medical Center" are "Drug" (74 trials), "Other" (68 trials), "Biological" (38 trials), "Procedure" (16 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (24 trials), "Paclitaxel" (19 trials), "Carboplatin" (16 trials) and "Bevacizumab" (13 trials). Other intervention names were less common.

The vast majority of trials in "Dekalb Medical Center" are 66 trials for "All" genders and 31 trials for "Female" genders.

Currently, there are NaN active trials in "Dekalb Medical Center". undefined are not yet recruiting, 5 are recruiting, 47 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Dekalb Medical Center, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Dekalb Medical Center, 2 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".